07Dec
Private Equity Dealmakers Guidebook to Healthcare M&A During the Covid-19 Pandemic
The COVID-19 pandemic has stressed the M&A market at every stage of the deal-making process – from complicating on-site visits and intensifying the diligence process to introducing valuation gaps (relative to pre-COVID-19 expectations), complicating purchase agreement negotiations and limiting the availability of debt financing. Despite these hurdles, healthcare dealmakers have continued to pursue attractive acquisition opportunities throughout 2020, with the healthcare M&A market substantially...
By:
Bass, Berry & Sims PLC
Related
With the usual flurry of activity at the end of the legislative session, California has enacted a sl...
Read More >
Under the Fair Labor Standards Act, to avoid paying overtime for work performed by “white collar” ...
Read More >
Since the UK's referendum on EU membership in June 2016, there has been significant uncertainty over...
Read More >
In recent weeks, the Office of Federal Contract Compliance Programs (“OFCCP”) has entered into fou...
Read More >
Employees Fired Soon After Seizures, Federal Agency Charges - DENVER - The U.S. Equal Employment O...
Read More >
On October 10, 2019, California Gov. Gavin Newsom signed Assembly Bill 51 (AB 51) into law, prohibit...
Read More >